The Jewel P-WCD detects and treats life-threatening ventricular tachycardia and ventricular fibrillation, and is designed to promote compliance and fit into a patient’s daily life.

Providers:

Login to the clinical portal to access important information about the Jewel.

The Jewel P-WCD detects and treats life-threatening ventricular tachycardia and ventricular fibrillation, and is designed to promote compliance and fit into a patient’s daily life.

Providers:

Login to the clinical portal to access important information about the Jewel.

The Jewel Purpose and Overview

The Jewel continuously monitors a patient’s heart activity, detects ventricular tachycardia and ventricular fibrillation, and automatically delivers an electrical shock to restore normal heart rhythms.

You have prescribed the Jewel to your patient for a temporary period so that they are protected from specific life-threatening heart rhythms 24 hours a day, 7 days a week. The Jewel is not an implanted device. It is a device that is externally worn on the patient’s skin.

Clinical Trial Description

The Jewel IDE Study

A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest.

Objective

To demonstrate the safety and clinical effectiveness of the Jewel P-WCD.

Principal Investigators

Javed Butler, MD

University of Mississippi

  • President of the Baylor Scott and White Research Institute, Dallas, TX
  • Distinguished Professor of Medicine at the University of Mississippi Medical Center, Jackson, MS
  • Over 650 Peer-reviewed Publications
  • Member of Editorial Boards of Several Peer-reviewed Cardiovascular Journals

John Hummel, MD

The Ohio State University

  • Director, Electrophysiology Section
  • Professor of Cardiovascular Medicine
  • Over 150 Publications in Cardiac Electrophysiology

    Roxana Mehran, MD

    Mount Sinai

    • Director of Interventional Cardiovascular Research and Clinical Trials

    • Chief Scientific Officer, Clinical Trials Center, Cardiovascular Research Foundation

    • Member, Board of Trustees, Society of Cardiac Angiography and Interventions

      SCIENTIFIC ADVISORS

      Christine Albert, MD, MPH

      Cedars Sinai Medical Center

      • Professor and Founding Chair of the Department of Cardiology at Cedars Sinai
      • Epidemiologist at Brigham and Women’s Hospital
      • Visiting Professor of Harvard Medical School
      • Past President and current editorial member of the Heart Rhythm Society (HRS)
      • Lee and Harold Kapelovitz Distinguished Chair in Cardiology in the Smidt Heart Institute at Cedars-Sinai

      Bob Harrington, MD

      Stanford University

      • Interventional Cardiologist
      • Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University
      • Former Director of the Duke Clinical Research Institute (DCRI)
      • Author of more than 700 Articles and Edited Five Textbooks
      • Former Member and Chair of US FDA Cardiovascular and Renal Drugs Advisory Committee
      • Past President, American Heart Association

      Harlan Krumholz, MD

      Yale School of Medicine

      • Cardiologist
      • Director of Yale Center for Outcomes Research and Evaluation
      • Harold H. Hines Jr Professor Yale School of Medicine
      • Global Thought Leader on Outcomes Research
      • Author of more than 1,400 Articles and Two Books
      • National Academy of Medicine; Distinguished Scientist of the AHA

      Karol Watson, MD, PhD

      David Geffen School of Medicine at UCLA

      • Director of the UCLA Women’s Cardiovascular Health Center, the UCLA-Barbra Streisand Women’s Heart Health Program, and the UCLA Fellowship Program In Cardiovascular Diseases
      • Co-Director of the UCLA Program in Preventive Cardiology
      • Ad hoc Chair of the Clinical Chemistry and Clinical Toxicology Devices Panel of the Food and Drug Administration (FDA)
      • Past chairperson of the scientific advisory board For Womenheart
      • Past Vice President for the Association of Black Cardiologists (ABC)
      • More than 100 publications and presentations

        This product is not currently commercially available for sale in the U.S.